Bleomycin promotes cellular senescence and activation of the cGAS-STING pathway without direct effect on fibrosis in an idiopathic pulmonary fibrosis model
Aging · 2025
DOI: 10.18632/aging.206312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2025. Verfasst von Yoko Miura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodevelopmental Disorder Genetics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Bleomycin, Cellular Senescence, Idiopathic Pulmonary Fibrosis, Membrane Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Bleomycin is an effective anticancer agent that causes drug-induced interstitial pneumonia (IP). Medical history is a risk factor for adverse effects, particularly a history of IP and age-related fibrosis. Anti-cancer drugs for lung cancer with idiopathic pulmonary fibrosis (IPF) often aggravate pulmonary fibrosis. Thus, we examined the pathological effects of bleomycin, an anticancer drug, in precision-cut lung slices (PCLS) of lungs with usual interstitial pneumonia (UIP). We found that the lungs of mice with induced UIP (iUIP), which exhibit a pathology similar to that of IPF, underwent accelerated senescence. Treatment of iUIP PCLS with bleomycin reduced the nuclear membrane component lamin B1 and nuclear DNA with γH2AX leaked into the cytoplasm. This perinuclear DNA may activate NF-κB through the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway. As a result, the unresolved DNA damage associated with the failure of DNA repair and senescence progression is more advanced in these cells. However, Col1a1 and Acta2 expression was not induced in either bleomycin-treated normal or iUIP PCLS, suggesting that there was no direct fibrotic effect on the lungs. We concluded that lungs with iUIP exhibited accelerated senescence following bleomycin treatment, leading to cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodevelopmental Disorder Genetics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Medicine, McMaster University, Hamilton, Canada.
- Department of Medicine, Division of Respirology, Firestone Institute for Respiratory Health, McMaster University, Hamilton, Canada.
Zitieren
APA
Miura, Y., Milad, N., Takata, A., & Kanazawa, S. (2025). Bleomycin promotes cellular senescence and activation of the cGAS-STING pathway without direct effect on fibrosis in an idiopathic pulmonary fibrosis model. Aging. https://doi.org/10.18632/aging.206312
Vancouver
Miura Y, Milad N, Takata A, Kanazawa S. Bleomycin promotes cellular senescence and activation of the cGAS-STING pathway without direct effect on fibrosis in an idiopathic pulmonary fibrosis model. Aging. 2025. doi:10.18632/aging.206312
BibTeX
@article{Miura2025,
author = {Miura, Yoko and Milad, Nadia and Takata, Akiho and Kanazawa, Satoshi},
title = {Bleomycin promotes cellular senescence and activation of the cGAS-STING pathway without direct effect on fibrosis in an idiopathic pulmonary fibrosis model},
journal = {Aging},
year = {2025},
doi = {10.18632/aging.206312}
}
EUVIMED